i-SEP
PrivateLast Round
VC Round
Jan 14, 2026
Est. Valuation
$8.72M
Total Funding Raised
$4.89M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
i-SEP operates in Healthcare & Life Sciences and is based in Nantes. Its latest recorded funding round was a VC Round in January 2026.
i-SEP is a biotechnology company that develops and markets innovative intraoperative autotransfusion and Patient Blood Management solutions for hemorrhagic surgeries.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
i-SEP Comparables
Compare i-SEP with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tecnoline S.p.A. | 78% | |
| Brightwake Ltd | 78% | |
| Fresenius SE & Co. KGaA | 76% |
For institutional investors. Book with your work email.
i-SEP Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 14, 2026 | ||||
| VC Round | Sep 26, 2019 | ||||
| Grant | Oct 23, 2018 | ||||
| VC Round | May 4, 2017 | ||||
| Seed | Oct 28, 2015 |
For institutional investors. Book with your work email.
i-SEP Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GwenneG | VC Round |
| GO Capital | VC Round, Seed |
| WiSeed | VC Round |
| Bpifrance | Grant |
| Région Pays de la Loire | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors increased 65% MoM.
- May 16, 2026
Monthly visitors increased 387% MoM.
For institutional investors. Book with your work email.
i-SEP Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about i-SEP's valuation, stock price, and market status.
Is i-SEP a public or private company?
i-SEP is a private company.
What is the current stock price of i-SEP?
i-SEP is a private company, so its shares have no public market price. Caplight tracks i-SEP's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is i-SEP worth (valuation)?
i-SEP's valuation is estimated at $8.7M based on funding round data.
Can I buy i-SEP stock?
i-SEP shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was i-SEP's last funding round?
i-SEP's most recent funding round was VC Round on January 14, 2026.
Who are the main investors in i-SEP?
Key investors in i-SEP include GO Capital.
Will i-SEP IPO soon?
No public IPO plans have been announced for i-SEP.
How can I track i-SEP secondary market activity?
Caplight tracks bids, offers, and trades in i-SEP's shares on secondary markets.